The biology of leptin and its implications in breast cancer: A general view

Journal of Interferon and Cytokine Research

Volumn 33, Issue 12, 2013, Pages 717-727

  García Robles, Mayra J ^a   Segura Ortega, Jorge E ^b   Fafutis Morris, Mary ^a  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 6; LEPTIN; LEPTIN RECEPTOR; STAT3 PROTEIN; VASCULOTROPIN;

ALTERNATIVE RNA SPLICING; ANGIOGENESIS; APPETITE; BODY WEIGHT; BREAST CANCER; CANCER SURVIVAL; CELL PROLIFERATION; DISEASE COURSE; ENERGY BALANCE; GENE MUTATION; HUMAN; HYPOTHALAMUS; IN VITRO STUDY; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR INVASION;

ANIMALS; BREAST NEOPLASMS; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; FEMALE; HOMEOSTASIS; HUMANS; LEPTIN; MICE; MOLECULAR TARGETED THERAPY; RECEPTORS, LEPTIN; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 84890087045     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2012.0168     Document Type: Review

References (95)

1. Artwohl M, Roden M, Hölzenbein T, Freudenthaler A, Waldhäusl W, Baumgartner-Parzer SM. 2002. Modulation by leptin of proliferation and apoptosis in vascular endothelial cells. Int J Obes 26(4): 577-580.
2. Bahary N, Leibel RL, Joseph L, Friedman JM. 1990. Molecular mapping of the mouse db mutation. Proc Natl Acad Sci U S A 87(21): 8642-8646.
3. Banks AS, Davis SM, Bates SH, Myers MG. 2000. Activation of downstream signals by the long form of the leptin receptor. J Biol Chem 275(19): 14563-14572.
4. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM. 1996. Leptin enters the brain by a saturable system independent of insulin. Peptides 17(2): 305-311.
5. Barr VA, Lane K, Taylor SI. 1999. Subcellular localization and internalization of the four human leptin receptor isoforms. J Biol Chem 274(30): 21416-21424.
6. Baumann H, Morella KK, White DW, Dembski M, Bailon PS, Kim H, Lai CF, Tartaglia LA. 1996. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc Natl Acad Sci U S A 93(16): 8374-8378.
7. Bjørbæk C, Elmquist JK, Michl P, Ahima RS, van Bueren A, McCall AL, Flier JS. 1998. Expression of leptin receptor isoforms in rat brain microvessels. Endocrinology 139(8):3485- 3491.
8. Bjørbæk C, Uotani S, da Silva B, Flier JS. 1997. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem 272(51): 32686-32695.
9. Bray SJ. 2006. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 7(9): 678-689.
10. Calle EE. 2007. Adiposity and cancer. In: Fantuzzi G, Mazzone T, eds. Adipose tissue and adipokines in health and disease. Totowa, New Jersey: Humana Press, Inc. pp. 307-339.
11. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. 1995. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269(5223): 546-549.
12. Carroll PA, Healy L, Lysaght J, Boyle T, Reynolds JV, Kennedy MJ, Pidgeon G, Connolly EM. 2011. Influence of the metabolic syndrome on leptin and leptin receptor in breast cancer. Mol Carcinog 50(8): 643-651.
13. Catalano S, Marsico S, Giordano C, Mauro L, Rizza P, Panno ML, Andò S. 2003. Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line. J Biol Chem 278(31):28668- 28676.
14. Chen D-C, Chung Y-F, Yeh Y-T, Chaung H-C, Kuo F-C, Fu O-Y, Chen H-Y, Hou M-F, Yuan S-SF. 2006. Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett 237(1): 109-114.
15. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, More KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP. 1996. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84(3): 491-495.
16. Cleary M, Phillips F, Getzin S, Jacobson T, Jacobson M, Christensen T, Juneja S, Grande J, Maihle N. 2003. Genetically obese MMTV-TGF-alpha/Lep ob Lep ob female mice do not develop mammary tumors. Breast Cancer Res Treat 77(3): 205-215.
17. Cleary MP, Juneja SC, Phillips FC, Hu X, Grande JP, Maihle NJ. 2004. Leptin receptor-deficient MMTV-TGF-a/LeprdbLeprdb female mice do not develop oncogene-induced mammary tumors. Exp Biol Med 229(2): 182-193.
18. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF. 1996. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334(5): 292-295.
19. Cota D, Proulx K, Smith KAB, Kozma SC, Thomas G, Woods SC, Seeley RJ. 2006. Hypothalamic mTOR signaling regulates food intake. Science 312(5775): 927-930.
20. Cowey S, Hardy RW. 2006. The metabolic syndrome: a high-risk state for cancer? Am J Pathol 169(5): 1505-1522.
21. De Matteis R, Dashtipour K, Ognibene A, Cinti S. 1998. Localization of leptin receptor splice variants in mouse peripheral tissues by immunohistochemistry. Proc Nutr Soc 57(03): 441-448.
22. Drabsch Y, Dijke Pt. 2011. TGF-b signaling in breast cancer cell invasion and bone metastasis. J Mammary Gland Biol Neoplasia 16(2):97108.
23. Fei H, Okano HJ, Li C, Lee G-H, Zhao C, Darnell R, Friedman JM. 1997. Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc Natl Acad Sci U S A 94(13): 7001-7005.
24. Ferla R, Bonomi M, Otvos L, Surmacz E. 2011. Glioblastomaderived leptin induces tube formation and growth of endothelial cells: comparison with VEGF effects. BMC Cancer 11(1):303.
25. Fiorio E, Mercanti A, Terrasi M, Micciolo R, Remo A, Auriemma A, Molino A, Parolin V, Di Stefano B, Bonetti F, Giordano A, Cetto G, Surmacz E. 2008. Leptin/HER2 crosstalk in breast cancer: in vitro study and preliminary in vivo analysis. BMC Cancer 8(1):305.
26. Frederich RC, Löllmann B, Hamann A, Napolitano-Rosen A, Kahn BB, Lowell BB, Flier JS. 1995. Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J Clin Invest 96(3): 1658-1663.
27. Garofalo C, Koda M, Cascio S, Sulkowska M, Kanczuga-Koda L, Golaszewska J, Russo A, Sulkowski S, Surmacz E. 2006. Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesityrelated stimuli. Clin Cancer Res 12(5): 1447-1453.
28. Garofalo C, Sisci D, Surmacz E. 2004. Leptin interferes with the effects of the antiestrogen ICI 182,780 in MCF-7 breast cancer cells. Clin Cancer Res 10(19): 6466-6475.
29. Ghilardi N, Ziegler S, Wiestner A, Stoffel R, Heim MH, Skoda RC. 1996. Defective STAT signaling by the leptin receptor in diabetic mice. Proc Natl Acad Sci U S A 93(13): 6231-6235.
30. Golden PL, Maccagnan TJ, Pardridge WM. 1997. Human bloodbrain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels. J Clin Invest 99(1): 14-18.
31. Gonzalez RR, Cherfils S, Escobar M, Yoo JH, Carino C, Styer AK, Sullivan BT, Sakamoto H, Olawaiye A, Serikawa T, Lynch MP, Rueda BR. 2006. Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2). J Biol Chem 281(36): 26320-26328.
32. Gonzalez RR, Watters A, Xu Y, iSingh U, Mann D, Rueda B, Penichet M. 2009. Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer. Breast Cancer Res 11(3):R36.
33. Gonzalez-Perez RR, Xu Y, Guo S, Watters A, Zhou W, Leibovich SJ. 2010. Leptin upregulates VEGF in breast cancer via canonic and non-canonical signalling pathways and NFkB/HIF-1a activation. Cell Signal 22(9): 1350-1362.
34. Guo S, Gonzalez-Perez RR. 2011. Notch, IL-1 and leptin crosstalk outcome (NILCO) Is critical for leptin-induced proliferation, migration and VEGF/VEGFR-2 expression in breast cancer. PLoS One 6(6):e21467.
35. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller- Newen G, Schaper F. 2003. Principles of interleukin (IL)-6- type cytokine signalling and its regulation. Biochem J 374(1): 1-20.
36. Hileman SM, Pierroz DD, Masuzaki H, Bjørbæk C, El-Haschimii K, Banks WA, Flier JS. 2002. Characterizaton of short isoforms of the leptin receptor in rat cerebral microvessels and of brain uptake of leptin in mouse models of obesity. Endocrinology 143(3): 775-783.
37. Hileman SM, Tornøe J, Flier JS, Bjørbæk C. 2000. Transcellular transport of leptin by the short leptin receptor isoform obra in madin-darby canine kidney cells. Endocrinology 141(6):1955- 1961.
38. Hill JW, Williams KW, Ye C, Luo J, Balthasar N, Coppari R, Cowley MA, Cantley LC, Lowell BB, Elmquist JK. 2008. Acute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin neurons in mice. J Clin Invest 118(5): 1796-1805.
39. Hu X, Juneja SC, Maihle NJ, Cleary MP. 2002. Leptin-A growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 94(22):1704- 1711.
40. Hummel KP, Dickie MM, Coleman DL. 1966. Diabetes, a new mutafton in the mouse. Science 153(3740): 1127-1128.
41. Imagawa K, Numata Y, Katsuura G, Sakaguchi I, Morita A, Kikuoka S, Matumoto Y, Tsuji T, Tamaki M, Sasakura K, Teraoka H, Hosoda K, Ogawa Y, Nakao K. 1998. Structurefunction studies of human leptin. J Biol Chem 273(52):35245- 35249.
42. Ingalls AM, Dickie MM, Snell GD. 1950. Obese, a new mutation in the house mouse. J Hered 41: 317-318.
43. Ishikawa M, Kitayama J, Nagawa H. 2004. Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 10(13): 4325-4331.
44. Iwata H, Iwase H, Toyama T, Hara Y, Omoto Y, Okada Y, Kobayashi S. 1996. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas. Jpn J Cancer Res 20(5): 602-611.
45. Iyengar P, Combs TP, Shah SJ, Gouon-Evans V, Pollard JW, Albanese C, Flanagan L, Tenniswood MP, Guha C, Lisanti MP, Pestell RG, Scherer PE. 2003. Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and protooncogene stabilization. Oncogene 22(41): 6408-6423.
46. JardéT, Caldefie-Chézet F, Damez M, Mishellany F, Penault- Llorca F, Guillot J, Vasson MP. 2008. Leptin and leptin receptor involvement in cancer development: a study on human primary breast carcinoma. Oncol Rep 19(4): 905-911.
47. Kershaw EE, Flier JS. 2004. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89(6): 2548-2556.
48. Kim Y-B, Uotani S, Pierroz DD, Flier JS, Kahn BB. 2000. In vivo administration of leptin activates signal transduction directly in insulin-sensitive tissues: overlapping but distinct pathways from insulin. Endocrinology 141(7): 2328-2339.
49. Koda M, Kanczuga-Koda L, Sulkowska M, Surmacz E, Sulkowski S. 2010. Relationships between hypoxia markers and the leptin system, estrogen receptors in human primary and metastatic breast cancer: effects of preoperative chemotherapy. BMC Cancer 10(1):320.
50. Koda M, Sulkowska M, Kanczuga-Koda L, Jarzabek K, Sulkowski S. 2007. Expression of leptin and its receptor in female breast cancer in relation with selected apoptotic markers. Folia Histochem Cytobiol 45(1): 187-191.
51. Lee G-H, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, Friedman JM. 1996. Abnormal splicing of the leptin receptor in diabetic mice. Nature 379(6566): 632-635.
52. Li C, Friedman JM. 1999. Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction. Proc Natl Acad Sci U S A 96(17): 9677-9682.
53. Lonnqvist F, Arner P, Nordfors L, Schalling M. 1995. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat Med 1(9): 950-953.
54. Maamra M, Bidlingmaier M, Postel-Vinay M-C, Wu Z, Strasburger CJ, Ross RJM. 2001. Generation of human soluble leptin receptor by proteolytic cleavage of membrane-anchored receptors. Endocrinology 142(10): 4389-4393.
55. Madej T, Boguski MS, Bryant SH. 1995. Threading analysis suggests that the obese gene product may be a helical cytokine. FEBS Lett 373(1): 13-18.
56. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM. 1995. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1(11): 1155-1161.
57. Masuzaki H, Ogawa Y, Isse N, Satoh N, Okazaki T, Shigemoto M, Mori K, Tamura N, Hosoda K, Yoshimasa Y. 1995. Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 44(7):855- 858.
58. Mauro L, Catalano S, Bossi G, Pellegrino M, Barone I, Morales S, Giordano C, Bartella V, Casaburi I, Andò S. 2007. Evidences that leptin up-regulates e-cadherin expression in breast cancer: effects on tumor growth and progression. Cancer Res 67(7): 3412-3421.
59. McMurtry V, Simeone A-M, Nieves-Alicea R, Tari A. 2009. Leptin utilizes Jun N-terminal kinases to stimulate the invasion of MCF-7 breast cancer cells. Clin Exp Metastasis 26(3): 197-204.
60. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Trayhurn P. 1996. Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett 387(2-3): 113-116.
61. Miyoshi Y, Funahashi T, Tanaka S, Taguchi T, Tamaki Y, Shimomura I, Noguchi S. 2006. High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels. Int J Cancer 118(6): 1414-1419.
62. Münzberg H, Huo L, Nillni EA, Hollenberg AN, Bjørbæk C. 2003. Role of signal transducer and activator of transcription 3 in regulation of hypothalamic proopiomelanocortin gene expression by leptin. Endocrinology 144(5): 2121-2131.
63. Nair P. 2005. Epidermal growth factor receptor family and its role in cancer progression. Curr Sci 88(6): 890-898.
64. Okumura M, Yamamoto M, Sakuma H, Kojima T, Maruyama T, Jamali M, Cooper DR, Yasuda K. 2002. Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-alpha and PPAR expression. Biochim Biophys Acta 1592(2): 107-116.
65. Otvos L, Kovalszky I, Riolfi M, Ferla R, Olah J, Sztodola A, Nama K, Molino A, Piubello Q, Wade JD, Surmacz E. 2011. Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer. Eur J Cancer 47(10): 1578-1584.
66. Otvos L, Surmacz E. 2011. Targeting the leptin receptor: a potential new mode of treatment for breast cancer. Expert Rev Anticancer Ther 11(8): 1147-1150.
67. Park J, Kusminski CM, Chua SC, Scherer PE. 2010. Leptin receptor signaling supports cancer cell metabolism through suppression of mitochondrial respiration in vivo. Am J Pathol 177(6): 3133-3144.
68. Perera CN, Chin HG, Duru N, Camarillo IG. 2008a. Leptinregulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression. J Endocrinol 199(2): 221-233.
69. Perera CN, Spalding HS, Mohammed SI, Camarillo IG. 2008b. Identification of proteins secreted from leptin stimulated MCF-7 breast cancer cells: a dual proteomic approach. Exp Biol Med 233(6): 708-720.
70. Révillion F, Charlier M, Lhotellier V, Hornez L, Giard S, Baranzelli M-C, Djiane J, Peyrat J-P. 2006. Messenger RNA expression of leptin and leptin receptors and their prognostic value in 322 human primary breast cancers. Clin Cancer Res 12(7): 2088-2094.
71. Rose DP, Vona-Davis L. 2010. Interaction between menopausal status and obesity in affecting breast cancer risk. Maturitas 66(1): 33-38.
72. Sachdev D, Yee D. 2001. The IGF system and breast cancer. Endoc-Relat Cancer 8(3): 197-209.
73. Savagner P. 2010. The epithelial-mesenchymal transition (EMT) phenomenon. Ann Oncol 21(suppl 7):vii89-vii92.
74. Saxena NK, Vertino PM, Anania FA, Sharma D. 2007. Leptininduced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3. J Biol Chem 282(18): 13316-13325.
75. Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG. 1996. Identification of targets of leptin action in rat hypothalamus. J Clin Invest 98(5): 1101-1106.
76. Simons PJ, van den Pangaart PS, van Roomen CPAA, Aerts JMFG, Boon L. 2005. Cytokine-mediated modulation of leptin and adiponectin secretion during in vitro adipogenesis: evidence that tumor necrosis factor-alpha- and interleukin-1betatreated human preadipocytes are potent leptin producers. Cytokine 32(2): 94-103.
77. Soares R, Balogh G, Guo S, Gärtner F, Russo J, Schmitt F. 2004. Evidence for the notch signaling pathway on the role of estrogen in angiogenesis. Mol Endocrinol 18(9): 2333-2343.
78. Soma D, Kitayama J, Yamashita H, Miyato H, Ishikawa M, Nagawa H. 2008. Leptin augments proliferation of breast cancer cells via transactivation of HER2. J Surg Res 149(1): 9-14.
79. Sonnenschein E, Toniolo P, Terry MB, Bruning PF, Kato I, Koenig KL, Shore RE. 1999. Body fat distribution and obesity in pre- and postmenopausal breast cancer. Int J Epidemiol 28(6): 1026-1031.
80. Szpirer C, Szpirer J. 2007. Mammary cancer susceptibility: human genes and rodent models. Mamm Genome 18(12): 817-831.
81. Tartaglia LA. 1997. The leptin receptor. J Biol Chem 272(10): 6093-6096.
82. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Wool EA, Monroe CA, Tepper RI. 1995. Identification and expression cloning of a leptin receptor, OB-R. Cell 83(7): 1263-1271.
83. Trayhurn P, Wood IS. 2004. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92: 347-355.
84. Truett GE, Bahary N, Friedman JM, Leibel RL. 1991. Rat obesity gene fatty (fa) maps to chromosome 5: evidence for homology with the mouse gene diabetes (db). Proc Natl Acad Sci U S A 88(17): 7806-7809.
85. Turner N, Grose R. 2010. Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer 10(2): 116-129.
86. Uotani S, Bjørbaek C, Tornøe J, Flier JS. 1999. Functional properties of leptin receptor isoforms: internalization and degradation of leptin and ligand-induced receptor downregulation. Diabetes 48(2): 279-286.
87. White DW, Kuropatwinski KK, Devos R, Baumann H, Tartaglia LA. 1997. Leptin Receptor (OB-R) Signaling. J Biol Chem 272(7): 4065-4071.
88. WHO. 2011. "Obesity and overweight Fact sheet N-311." from www.who.int/mediacentre/factsheets/fs311/en
89. Wu MH, Chou YC, Chou WY, Hsu GC, Chu CH, Yu CP, Yu JC, Sun CA. 2009. Circulating levels of leptin, adiposity and breast cancer risk. Br J Cancer 100(4): 578-582.
90. Xu W, Kimelman D. 2007. Mechanistic insights from structural studies of b-catenin and its binding partners. J Cell Sci 120(19): 3337-3344.
91. Yan D, Avtanski D, Saxena NK, Sharma D. 2012. Leptininduced epithelial-mesenchymal transition in breast cancer cells requires b-catenin activation via Akt/GSK3- and MTA1/ Wnt1 protein-dependent pathways. J Biol Chem 287(11):8598- 8612.
92. Yin N, Wang D, Zhang H, Yi X, Sun X, Shi B, Wu H, Wu G, Wang X, Shang Y. 2004. Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin. Cancer Res 64(16): 5870-5875.
93. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. 1995. Positional cloning of the mouse obese gene and its human homologue. Nature 374(6521): 479-479.
94. Zheng Q, Dunlap SM, Zhu J, Downs-Kelly E, Rich J, Hursting SD, Berger NA, Reizes O. 2011. Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival. Endoc-Relat Cancer 18(4): 491-503.
95. Zhou W, Guo S, Gonzalez-Perez RR. 2011. Leptin proangiogenic signature in breast cancer is linked to IL-1 signalling. Br J Cancer, 104: 128-137.